US Market Report for Insulin Pumps 2017 - MedCore

  • ID: 3960419
  • Report
  • Region: United States
  • 73 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
The total U.S. market for insulin pumps can be segmented by pump type, yielding three segments: traditional insulin pumps, patch insulin pumps and simple insulin pumps. In 2016, the largest segment in the total insulin pump market was the traditional pump segment. Traditional pumps account for such a large portion of the market because they are a much more established market, relative to the patch pump and simple pump markets, which were launched in the U.S. in 2005 and 2012, respectively. It is expected that traditional pumps will maintain their dominance over the forecast period, despite the growing market share of patch pumps and simple pumps.

Patch pumps are an attractive therapy option for the proportion of the patient population that values the wireless features and significant cost savings on the initial investment of the device, relative to traditional pumps. Although Insulet Corporation currently holds a monopoly in the U.S. market, Cellnovo and other competitors are expected to launch patch pump products over the forecast period and contribute to increased device uptake among the insulin-dependent diabetic population.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
Table Of Contents I
List Of Figures Iv
List Of Charts Vi
Executive Summary
U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Introduction
2.1.1 Types Of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes
2.1.4 Signs And Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
Insulin Pump Market
3.1 Introduction
3.1.1 Traditional Insulin Pumps
3.1.2 Patch Insulin Pumps
3.1.3 Simple Insulin Pumps
3.2 Market Overview
3.3 Market Analysis And Forecast
3.3.1 Total Traditional Insulin Pump Market
3.3.1.1 Traditional Pump Market
3.3.1.2 Infusion Set Market
3.3.1.3 Pump Reservoir Market
3.3.2 Total Patch Insulin Pump Market
3.3.2.1 Patch Pump System Market
3.3.2.2 Insulin Pod Market
3.3.3 Simple Insulin Pump Market
3.4 Drivers And Limiters
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 Competitive Market Share Analysis
Abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
Traditional insulin pumps, often referred to as durable pumps, offer constant and finer delivery of insulin to maintain precise control of glycemic levels. Traditional pumps feature a reservoir of insulin connected to the patient through plastic tubing and a cannula, referred to as an infusion set. A small computer controls the dosage, and is pre-programmed specifically for the patient. The insulin pump is used to deliver both basal and bolus insulin. Basal insulin is delivered continuously at a rate set by the user specific to the time of day. Bolus insulin is injected prior to eating based on what the patient plans to eat and their current blood glucose level. Infusion sets are typically replaced once every three days, while insulin reservoirs are typically replaced once every two to three days. New technological innovations in the traditional pump market include pumps with built-in continuous glucose monitoring (CGM), low glucose suspension algorithms and touchscreen interfaces.
Note: Product cover images may vary from those shown
5 of 5
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll